Chat with us
Research Assistance
Online
  • Please enter your first name.

North America Molecular Diagnostics Market Size & Outlook

The molecular diagnostics market in North America is expected to reach a projected revenue of US$ 13,347.1 million by 2030. A compound annual growth rate of 3.6% is expected of North America molecular diagnostics market from 2025 to 2030.
Revenue, 2024 (US$M)
$10,543.3
Forecast, 2030 (US$M)
$13,347.1
CAGR, 2025 - 2030
3.6%
Report Coverage
North America

North America Molecular Diagnostics Market, 2018-2030 (US$M)

North America Molecular Diagnostics Market, 2018-2030 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Global Market

Related Markets

North America molecular diagnostics market highlights

  • The North America molecular diagnostics market generated a revenue of USD 10,543.3 million in 2024.
  • The market is expected to grow at a CAGR of 3.6% from 2025 to 2030.
  • In terms of segment, reagents was the largest revenue generating product in 2024.
  • Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2030.


North America data book summary

Market revenue in 2024USD 10,543.3 million
Market revenue in 2030USD 13,347.1 million
Growth rate3.6% (CAGR from 2025 to 2030)
Largest segmentReagents
Fastest growing segmentReagents
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Reagents


Other key industry trends

  • In terms of revenue, North America region accounted for 40.9% of the global molecular diagnostics market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Latin America is the fastest growing regional market and is projected to reach USD 1,718.7 million by 2030.

North America holds the leading position in the global market, driven by the growing adoption of molecular diagnostics, which are valued for their superior accuracy, sensitivity, and specificity. The rising demand for genetic testing, particularly for personalized healthcare in conditions such as diabetes and cancer, is anticipated to fuel market expansion.

Additionally, strategic collaborations between prominent pharmaceutical firms and molecular diagnostic companies aimed at developing companion diagnostics are fostering significant growth opportunities in the region.

No credit card required*

Publish Date: Jan 08, 2025

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Three ways to get this data

Subscribe to the databook, customize it, or ask a question.

Horizon Databook

Unlock every chart on this page and get dashboard access

  • Statistics1.2M+ across all markets
  • Databooks30K+ global, 120K+ country
  • Companies200K+ profiles
  • ExportPDF, Dashboard, XLS & PNG, licensed to cite

Ask Prism AI

A cited answer in seconds

  • Corpus30,000 studies, 1.2M points
  • ScopeAll markets, not just this
  • CitationTraced to report & table
  • HonestySays "not covered" if so
  • SpeedSeconds, not days
ISO 9001 & 27001 certifiedESOMAR memberNot sure which fits? Call +1-415-854-0727

Molecular Diagnostics Market Companies

NameProfile# EmployeesHQWebsite
Abbott LaboratoriesView profile 114,000100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400www.abbottinvestor.com
Becton Dickinson & CoView profile 73,0001 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880www.bd.com
BioMerieux SAView profile 13,982Marcy l’Etoile, Lyon, France, 69280www.biomerieux.com
Siemens Healthineers AG ADRView profile 71,400Siemensstr. 3, Forchheim, BY, Germany, 91301www.siemens-healthineers.com
Danaher CorpView profile 63,0002200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701www.danaher.com
Illumina IncView profile 9,3005200 Illumina Way, San Diego, CA, United States, 92122www.illumina.com
Agilent Technologies IncView profile 17,7005301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051www.agilent.com
Bio-Rad Laboratories IncView profile 8,0301000 Alfred Nobel Drive, Hercules, CA, United States, 94547www.bio-rad.com
Qiagen NVView profile 5,900Hulsterweg 82, Venlo, LI, Netherlands, 5912 PLwww.qiagen.com
Hologic IncView profile 6,990250 Campus Drive, Marlborough, MA, United States, 01752www.hologic.com

North America Molecular Diagnostics Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Molecular Diagnostics Market Outlook will help companies and investors design strategic landscapes.


Reagents was the largest segment with a revenue share of 69.46% in 2024.

Horizon Databook has segmented the North America molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to 2030.




North America holds the leading position in the global market, driven by the growing adoption of molecular diagnostics, which are valued for their superior accuracy, sensitivity, and specificity. The rising demand for genetic testing, particularly for personalized healthcare in conditions such as diabetes and cancer, is anticipated to fuel market expansion.

Additionally, strategic collaborations between prominent pharmaceutical firms and molecular diagnostic companies aimed at developing companion diagnostics are fostering significant growth opportunities in the region.

  • North America Molecular Diagnostics Market Product Outlook (Revenue, USD Million , 2018-2030)
    • Instruments
    • Reagents
    • Others Product
  • North America Molecular Diagnostics Market Test Location Outlook (Revenue, USD Million , 2018-2030)
    • Point of care
    • Self test or OTC
    • Central laboratories
  • North America Molecular Diagnostics Market Technology Outlook (Revenue, USD Million , 2018-2030)
    • PCR
    • ISH
    • INAAT
    • Chips and microarrays
    • Mass spectrometry
    • Sequencing
    • TMA
    • Others Technology
  • North America Molecular Diagnostics Market Application Outlook (Revenue, USD Million , 2018-2030)
    • Oncology
    • Pharmacogenomics
    • Infectious disease
    • Genetic testing
    • Neurological disease
    • Cardiovascular disease
    • Microbiology
    • Others Application

Reasons to subscribe to Molecular Diagnostics Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Molecular Diagnostics Market Outlook databook

  • Our clientele includes a mix of Molecular Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America Molecular Diagnostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Molecular Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.

North America Molecular Diagnostics Market, 2018-2030 (US$M)

No Access Stack Chart

North America Product - Molecular Diagnostics Market Statistics, 2024 - 2030 (US$M)

No Access Pie Chart

North America molecular diagnostics market statistics, by country, 2018-2030 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more